4.8 Article

Proteogenomic Characterization of Human Early-Onset Gastric Cancer

Journal

CANCER CELL
Volume 35, Issue 1, Pages 111-+

Publisher

CELL PRESS
DOI: 10.1016/j.ccell.2018.12.003

Keywords

-

Funding

  1. Collaborative Genome Program for Fostering New Post-Genome Industry [2012M3A9B9028156, NRF-2017M3C9A5031397]
  2. Institute for Basic Science - Korean Ministry of Science and ICT (MSIT) [IBS-R013-A1]
  3. Korea Institute of Science and Technology (KIST)
  4. U.S. National Cancer Institute's Office of Cancer Clinical Proteomics Research (Clinical Proteomic Tumor Analysis Consortium program-CPTAC)
  5. Korean Ministry of Health and Welfare

Ask authors/readers for more resources

We report proteogenomic analysis of diffuse gastric cancers (GCs) in young populations. Phosphoproteome data elucidated signaling pathways associated with somatic mutations based on mutation-phosphorylation correlations. Moreover, correlations between mRNA and protein abundances provided potential oncogenes and tumor suppressors associated with patient survival. Furthermore, integrated clustering of mRNA, protein, phosphorylation, and N-glycosylation data identified four subtypes of diffuse GCs. Distinguishing these subtypes was possible by proteomic data. Four subtypes were associated with proliferation, immune response, metabolism, and invasion, respectively; and associations of the subtypes with immune-and invasion-related pathways were identified mainly by phosphorylation and N-glycosylation data. Therefore, our proteogenomic analysis provides additional information beyond genomic analyses, which can improve understanding of cancer biology and patient stratification in diffuse GCs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available